Twist Bioscience rises as quarterly revenue beats estimates
18/11/2024 13:58
** Synthetic biological products maker Twist Bioscience's
TWST.O shares rise 13.8% to $41.99 premarket
** Co's fiscal Q4 rev of $84.7 mln beats analysts' est of
$82.2 mln - LSEG
** Co reports fiscal Q4 loss of 59 cents/share, smaller than
analysts' est of a loss of 71 cents/share - LSEG
** Co forecasts rev of $367 mln to $377 mln for fiscal year
ending Sept 2025 vs est of $371.4 mln - LSEG
** TWST also forecasts Q1 FY25 rev of ~87 mln
** Nine of 12 brokerages rate the stock "buy" or higher, 2
"hold" and 1 "sell"; their median PT is $54 - LSEG
** As of last close, stock has risen 0.1% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))